Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Reexamination Certificate
2006-03-07
2006-03-07
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
C424S464000, C514S152000
Reexamination Certificate
active
07008631
ABSTRACT:
A method for simultaneously treating ocular rosacea and acne rosacea in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat ocular rosacea and acne rosacea but has substantially no antibiotic activity.
REFERENCES:
patent: 4957918 (1990-09-01), Martin et al.
patent: 5908838 (1999-06-01), Gans
patent: 6015803 (2000-01-01), Wirostko
patent: 6296880 (2001-10-01), Murad
patent: 6384081 (2002-05-01), Berman
patent: 6455583 (2002-09-01), Pflugfelder et al.
patent: 6495158 (2002-12-01), Buseman et al.
patent: 6664287 (2003-12-01), Avery et al.
patent: 2004/0092491 (2004-05-01), Nieman et al.
patent: 99/58131 (1999-11-01), None
patent: WO 9958131 (1999-11-01), None
patent: 00/07601 (2000-02-01), None
Bikowski JB “Treatment of rosacea with doxycycline monohydrate”, Cutis, Aug. 2000, 66(2): 149-52.
Nazir et al. “Ocular rosacea in childhood”, Am J Ophthalmol, Jan. 2004: 137(1):138-44.
Quarterman et al. “Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline” Arch Dermatol, Jan. 1997; 133(1):49-54.
Freinkel et al. “Effect of tetracycline on the composition of sebum in acne vulgaris.”New England Journal of Medicine, 1965, vol. 273, No. 16, pp. 850-854, (abstract only).
Dursun D. et al. “Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids.”Am. J. Ophthalmol., 132(1):8-13 (Jul. 2001).
Dursun D. et al. “Pseudokeratoconus caused by rosacea.”Cornea, 20(6):668-9 (Aug. 2001).
Li DQ, et al. “Regulation of MMP-9 production by human corneal epithelial cells.”Exp. Eye Res., 73(4):449-59 (Oct. 2001).
Solomon A., et al. “Doxycycline inhibition of interleukin-1 in the corneal epithelium.”Invest. Ophthalmol Vis. Sci., 41(9):2544-57 (Aug. 2000).
Sobrin L., et al. “Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.”Invest. Ophthalmol. Vis. Sci., 41(7):1703-9 (Jun. 2000).
Gilbard JP., et al. “Dry eye, blepharitis and chronic eye irritation: divide and conquer.”J. Ophthalmic Nurs. Technology, 18(3): 109-15 (May-Jun. 1999).
Bikowksi, J.B., “Treatment of rosacea with doxycycline monohydrate,” Curtis. Aug. 2000, 66(2):149-152.
Jimenez-Acosta, “Response to tetracycline of telanglectasias in male hemophiliac with human immunodeficiency virus infection,” J. Am. Acad. Dermatol. Aug. 1988, 19(2 Pt. 1):369-379.
Torresani, C., “Clarithromycin versus doxycycline in the treatment of rosacea,” Int. J. Clin. Dermatol Dec. 1997, 36(12):942-946.
McClellan, K.J., “Topical Metronidazole. A review of its use in rosaea,” Am. J. Clin. Dermatol. May-Jun. 2000, 1(3):191-199.
Quarterman, M.J., “Ocular Rosacea. Signs, symptoms and tear studies before and after treatment with doxycycline,” Arch. Dermatol. Jan. 1997, 133(1):49-54.
CollaGenex Pharmaceuticals, Inc.
Hoffmann & Baron , LLP
Page Thurman K.
Tran S.
LandOfFree
Methods of simultaneously treating ocular rosacea and acne... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of simultaneously treating ocular rosacea and acne..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of simultaneously treating ocular rosacea and acne... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3553311